Pustular Psoriasis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Pustular Psoriasis

What is the definition of Pustular Psoriasis?
Pustular psoriasis is a rare form of psoriasis that is characterized by widespread pustules and reddish skin. This condition can occur alone or with plaque-type psoriasis. Most cases of Pustular psoriasis are thought to be "multifactorial" or associated with the effects of multiple genes in combination with lifestyle and environmental factors. There are several triggers for this conditions including withdrawal from corticosteroids, exposure to various medications and/or infections. Some cases of the generalized form are caused by changes in the IL36RN gene and are inherited in an autosomal recessive pattern. In severe cases, hospitalization may be required.
What are the alternative names for Pustular Psoriasis?
  • Pustular psoriasis
Who are the top Pustular Psoriasis Local Doctors?
Elite in Pustular Psoriasis
Dermatology
Elite in Pustular Psoriasis
Dermatology
117 Albany Tpke, 
Canton, CT 
Languages Spoken:
English

Bruce Strober is a Dermatologist practicing medicine in Canton, Connecticut. Dr. Strober is rated as an Elite provider by MediFind in the treatment of Pustular Psoriasis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Plaque Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).

Elite in Pustular Psoriasis
Elite in Pustular Psoriasis
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Diamant Thaci practices practicing medicine in Luebeck, Germany. Thaci is rated as an Elite expert by MediFind in the treatment of Pustular Psoriasis. They are also highly rated in 18 other conditions, according to our data. Their clinical expertise encompasses Psoriasis, Plaque Psoriasis, Atopic Dermatitis, and Psoriatic Arthritis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pustular Psoriasis
Elite in Pustular Psoriasis
1500 E Medical Center Dr # 1910, 
Ann Arbor, MI 
Languages Spoken:
English

Johann Gudjonsson, MD, PhD is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. A graduate of the University of Iceland Medical School, he completed his internship and dermatology residency training at the University of Michigan. Dr. Gudjonsson has served on the faculty of the University of Michigan Department of Dermatology since 2008. He provides general medical dermatology patient care at the University of Michigan Taubman Center and maintains clinical and research interests in inflammatory and autoimmune disorders involving the skin.Dr. Gudjonsson came to the U-M in 2003 as part of an innovative research residency training program. Building upon investigative dermatology training completed in Iceland, Dr. Gudjonsson has been performing basic immunological and genetic work on psoriasis at the U-M. Dr. Gudjonsson's primary research focus is basic immunological and genetic research on psoriasis, with projects directed at improving the diagnosis and treatment of psoriasis. He received the 2007 Young Investigator Award from the American Academy of Dermatology, was named the 2018 Rising Star Lecturer for the Society for Investigative Dermatology and was recipient of the American Skin Association Research Achievement Award in Psoriasis in 2021. Dr. Gudjonsson's research has been supported by research awards from the National Institutes of Health (NIH), the American Skin Association, Dermatology Foundation, Doris Duke Foundation, among others. Dr. Gudjonsson is rated as an Elite provider by MediFind in the treatment of Pustular Psoriasis. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Darier Disease, Benign Chronic Pemphigus, Cutaneous Lupus Erythematosus (CLE), and Vitrectomy. Dr. Gudjonsson is board certified in Dermatology.

What are the latest Pustular Psoriasis Clinical Trials?
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of TQH2929 Injection in Patients With Acute Exacerbations of Generalized Pustular Psoriasis

Summary: This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study, all subjects need to use TQH2929 injection/placebo. The aim was to demonstrate the efficacy and safety of TQH2929 injection in patients with acute exacerbations of generalized pustular psoriasis, with a total of 36 subjects.

Match to trials
Find the right clinical trials for you in under a minute
Get started
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Summary: Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center